Medipost Co Ltd - ESG Rating & Company Profile powered by AI
The dashboard includes a questions and answers section for Medipost Co Ltd. This Sustainability score for Medipost Co Ltd indicates its reporting of the United Nations Sustainable Development Goals. The webpage contains a free Environmental, Social and Governance assessment covering Medipost Co Ltd.
Medipost Co Ltd in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Analytik Jena AG | 8.0 | High |
| 1 | Amniotics AB (publ) | 8.0 | High |
| ... | ... | ... | |
| 179 | Exagen Inc | 0.7 | Low |
| 179 | Mertiva AB | 0.7 | Low |
| 182 | Medipost Co Ltd | 0.0 | Low |
| 182 | Cadus Corp | 0.0 | Low |
| 182 | Cambridge Chocolate Technologies SA | 0.0 | Low |
| 182 | Wesana Health Holdings Inc | 0.0 | Low |
| 182 | rEVO Biologics Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Medipost Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Medipost Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Medipost Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Medipost Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Medipost Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Medipost Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Medipost Co Ltd offer flexible work?
Sign up for free to unlockDoes Medipost Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Medipost Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Medipost Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Medipost Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Medipost Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Medipost Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Medipost Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Medipost Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Medipost Co Ltd disclose water use targets?
Sign up for free to unlockDoes Medipost Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Medipost Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Medipost Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Medipost Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Medipost Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Medipost Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Medipost Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Medipost Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Medipost Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Medipost Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Medipost Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Medipost Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Medipost Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Medipost Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Medipost Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Medipost Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Medipost Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Medipost Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Medipost Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Medipost Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Medipost Co Ltd
These potential risks are based on the size, segment and geographies of the company.
MEDIPOST Co., Ltd. provides stem cell therapeutic solutions to meet the unmet medical needs in South Korea and internationally. It operates CELLTREE, an umbilical cord blood bank; and offers cord blood banking services to treat various incurable diseases. The company also markets CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell drugs, such as PNEUMOSTEM, which is in completed Phase II clinical trial in South Korea, as well as in Phase I/II clinical trial in the United States for the preventative treatment of bronchopulmonary dysplasia; and NEUROSTEM that is in Phase I/IIa clinical study to treat Alzheimer's disease. Further, the company develops SMUP-IA-01, which has completed phase I clinical trial for the treatment of osteoarthritis; and SMUP-IV-01 for the treatment of diabetic nephropathy, as well as offers nutritional and dietary supplements under the MOVITA brand name. MEDIPOST Co., Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea.